Advisory - Adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccineCanada NewsWireOTTAWA, ON, March 11, 2021OTTAWA, ON, March 11, 2021 /CNW/ -IssueHealth Canada is aware of reports of adverse events in Europe following immunization with the AstraZeneca COVID-19 vaccine, and would like to reassure Canadians that the benefits of the vaccine continue to outweigh its risks. Health Canada authorized the vaccine based on a thorough, independent review of the evidence and determined that it meets Canada's stringent safety, efficacy and quality requirements.